These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20978895)

  • 1. Plasma concentrations of soluble CD40 ligand in smokers with acute myocardial infarction: a pilot study.
    Kayrak M; Bacaksiz A; Ulgen MS; Vatankulu MA; Zengin K; Ayhan SS; Basaralı MK; Büyükbas S; Kiyici A
    Heart Vessels; 2011 Mar; 26(2):131-7. PubMed ID: 20978895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD40 ligand in acute coronary syndromes.
    Heeschen C; Dimmeler S; Hamm CW; van den Brand MJ; Boersma E; Zeiher AM; Simoons ML;
    N Engl J Med; 2003 Mar; 348(12):1104-11. PubMed ID: 12646667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of some cardiovascular risk factors on the expression of platelet glycoprotein IIb/IIIa receptors in patients with myocardial infarction treated with antiplatelet drugs under primary percutaneous coronary intervention.
    Konopka A; Spychalska J; Piotrowski W; Stepińska J
    Mol Diagn Ther; 2009 Dec; 13(6):375-82. PubMed ID: 19925035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40 ligand: a novel target in the fight against cardiovascular disease.
    Vishnevetsky D; Kiyanista VA; Gandhi PJ
    Ann Pharmacother; 2004 Sep; 38(9):1500-8. PubMed ID: 15280513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.
    Garlichs CD; Eskafi S; Raaz D; Schmidt A; Ludwig J; Herrmann M; Klinghammer L; Daniel WG; Schmeisser A
    Heart; 2001 Dec; 86(6):649-55. PubMed ID: 11711459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide. The PURSUIT trial investigators.
    Hasdai D; Holmes DR; Criger DA; Topol EJ; Califf RM; Wilcox RG; Paolasso E; Simoons M; Deckers J; Harrington RA
    Am Heart J; 2000 Mar; 139(3):454-60. PubMed ID: 10689260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activation is associated with myocardial infarction in patients with pneumonia.
    Cangemi R; Casciaro M; Rossi E; Calvieri C; Bucci T; Calabrese CM; Taliani G; Falcone M; Palange P; Bertazzoni G; Farcomeni A; Grieco S; Pignatelli P; Violi F; ;
    J Am Coll Cardiol; 2014 Nov; 64(18):1917-25. PubMed ID: 25444147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of circulating soluble CD40 ligand concentrations and the incidence of cardiovascular disease in a nested prospective case-control study of older men and women.
    Jefferis BJ; Whincup PH; Welsh P; Wannamethee SG; Rumley A; Lawlor DA; Ebrahim S; Lowe GD
    J Thromb Haemost; 2011 Aug; 9(8):1452-9. PubMed ID: 21696538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers.
    Harding SA; Sarma J; Josephs DH; Cruden NL; Din JN; Twomey PJ; Fox KA; Newby DE
    Circulation; 2004 Apr; 109(16):1926-9. PubMed ID: 15078798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy.
    Pride YB; Mohanavelu S; Zorkun C; Kunadian V; Giugliano RP; Newby LK; Braunwald E; Califf RM; Harrington RA; Gibson CM;
    JACC Cardiovasc Interv; 2012 Sep; 5(9):927-35. PubMed ID: 22995880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The platelet CD40L/GP IIb-IIIa axis in atherothrombotic disease.
    Prasad KS; Andre P; Yan Y; Phillips DR
    Curr Opin Hematol; 2003 Sep; 10(5):356-61. PubMed ID: 12913790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization.
    Furman MI; Krueger LA; Linden MD; Barnard MR; Frelinger AL; Michelson AD
    J Am Coll Cardiol; 2004 Jun; 43(12):2319-25. PubMed ID: 15193700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy).
    Robertson JO; Ebrahimi R; Lansky AJ; Mehran R; Stone GW; Lincoff AM
    JACC Cardiovasc Interv; 2014 Apr; 7(4):372-9. PubMed ID: 24630881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome.
    Mälarstig A; Lindahl B; Wallentin L; Siegbahn A
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1667-73. PubMed ID: 16627810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
    Choudhury A; Chung I; Panja N; Patel J; Lip GYH
    Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GP IIb/IIIa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention.
    Welt FG; Rogers SD; Zhang X; Ehlers R; Chen Z; Nannizzi-Alaimo L; Phillips DR; Simon DI
    Catheter Cardiovasc Interv; 2004 Feb; 61(2):185-9. PubMed ID: 14755809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IIb/IIIa receptor blockade in acute myocardial infarction.
    Ferguson JJ; Taqi K
    Am Heart J; 1999 Aug; 138(2 Pt 2):S164-70. PubMed ID: 10426877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights.
    Haig C; Carrick D; Carberry J; Mangion K; Maznyczka A; Wetherall K; McEntegart M; Petrie MC; Eteiba H; Lindsay M; Hood S; Watkins S; Davie A; Mahrous A; Mordi I; Ahmed N; Teng Yue May V; Ford I; Radjenovic A; Welsh P; Sattar N; Oldroyd KG; Berry C
    JACC Cardiovasc Imaging; 2019 Jun; 12(6):993-1003. PubMed ID: 30031700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating soluble CD40 ligand mediates the interaction between neutrophils and platelets in acute coronary syndrome.
    Setianto BY; Hartopo AB; Gharini PP; Anggrahini DW; Irawan B
    Heart Vessels; 2010 Jul; 25(4):282-7. PubMed ID: 20676835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.
    Ferro D; Loffredo L; Polimeni L; Fimognari F; Villari P; Pignatelli P; Fuster V; Violi F
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2763-8. PubMed ID: 17901373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.